Taking every one of these needles in the haystacks that we find seriously, that were examining, scrutinizing the data that we are seeing and people have said in that context that they have gained confidence in our vaccine safety system. Reporter all right. So this was not an easy decision for the advisory board. It was a split vote. Ten voting for bringing it back to market with that warning label, but four voted against the decision. One saying that they just wanted more information put out there on the risk to women specifically ages 18 to 49 years old. That is where we have seen the majority of the cases of this rare Blood Clotting issue that has come about. Now, what does this mean moving forward with this Johnson Johnson vaccine coming back out . Well, the panel says that and Johnson Johnson, i should say, specifically says that they have 9 million doses ready to go starting today as early as today, and it will mean sites like the one behind me can open up more appointments. In fa
Pennsylvania has had the unfortunate distinction of leading the nation in Lyme disease cases for 11 of the past 13 years. The tick-borne illness can be difficult to diagnose, and the vice president for the PA Lyme Disease Network said multiple mild winters are not going to help. “We continue
The company that ran Pennsylvania’s contact tracing program during the pandemic will pay nearly $3 million for allegedly failing to protect the private medical and personal information of more than 100,000 residents of Pennsylvania.